Archon Capital Lowers KORU Medical Stake to 5.0%

TL;DR

**Archon Capital cut its KORU Medical stake to 5.0%, watch for potential price reaction.**

AI Summary

Archon Capital Management LLC, a Washington-based investment firm, filed an amended SC 13G/A on February 13, 2024, disclosing its ownership in KORU Medical Systems, Inc. As of December 31, 2023, Archon beneficially owned 3,720,876 shares of KORU's common stock, representing 5.0% of the company's outstanding shares. This filing indicates a passive investment, as Archon's ownership has decreased from a previous filing, which could signal a shift in institutional confidence or portfolio rebalancing, potentially impacting investor sentiment for KORU Medical Systems.

Why It Matters

A decrease in institutional ownership, even if passive, can signal a re-evaluation of the stock's prospects by a significant investor, potentially influencing other investors' decisions and the stock's price.

Risk Assessment

Risk Level: medium — A reduction in institutional ownership can sometimes precede further selling pressure or indicate a lack of strong conviction from a major holder.

Analyst Insight

Investors should monitor KORU Medical Systems, Inc.'s stock performance and other institutional filings to gauge broader sentiment, as a reduction in a significant holder's stake could signal a re-evaluation of the company's prospects. Consider this in the context of other news and the company's fundamentals.

Key Numbers

• 3,720,876 — Shares Beneficially Owned (Number of KORU Medical Systems, Inc. shares Archon Capital Management LLC holds with shared voting and dispositive power.)
• 5.0% — Percentage of Class (The percentage of KORU Medical Systems, Inc.'s common stock beneficially owned by Archon Capital Management LLC.)

Key Players & Entities

• Archon Capital Management LLC (company) — the reporting person and investment firm
• KORU Medical Systems, Inc. (company) — the subject company whose shares are being reported
• Washington (company) — place of organization for Archon Capital Management LLC
• December 31, 2023 (date) — date of event requiring the filing

Forward-Looking Statements

• KORU Medical Systems, Inc. stock may experience short-term selling pressure due to the disclosed reduction in institutional ownership. (KORU Medical Systems, Inc.) — medium confidence, target: Q1 2024

FAQ

Key Financial Figures

• $0.01 — Inc. (Name of Issuer) Common Stock, $0.01 Par Value (Title of Class of Securiti

Filing Documents

• d10971984_13g-a.htm (SC 13G/A) — 94KB
• 0000919574-24-000913.txt ( ) — 96KB

From the Filing

SC 13G/A 1 d10971984_13g-a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* KORU Medical Systems, Inc. (Name of Issuer) Common Stock, $0.01 Par Value (Title of Class of Securities) 759910102 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [_] Rule 13d-1(c) [_] Rule 13d-1(d) __________ *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes) CUSIP No 759910102 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Archon Capital Management LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [_] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Washington NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 3,720,876 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 3,720,876 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,720,876 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.15% 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO, IA CUSIP No 759910102 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Constantinos Christofilis 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [_] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION United States NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 3,720,876 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 3,720,876 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,720,876 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.15% 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN, HC CUSIP No 759910102 Item 1. (a). Name of Issuer: KORU Medical Systems, Inc. (b). Address of issuer’s principal executive offices: 100 Corporate Drive Mahwah, New Jersey 07430 Item 2. (a). Name of person filing: Archon Capital Management LLC Constantinos Christofilis (b). Address of principal business office, or if none, residence: Archon Capital Management LLC 1100 19 th Avenue E Seattle, Washington 98112 Constantinos Christofilis c/o Archon Capital Management LLC 1100 19 th Avenue E Seattle, Washington 98112 (c). Citizenship: Archon Capital Management LLC – Washington Constantinos Christofilis – United States (d). Title of class of securities: Common Stock, $0.01 Par Value (e). CUSIP No.: 759910102 Item 3. If this Statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a: (a) [_] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78c). (b) [_] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [_] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [_] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [X] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); (f) [_] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); (g) [X] A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); (h) [_] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813); (i) [_] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [_] A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J); (k) [_] Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: Item 4. Provide t

View Full Filing

View this SC 13G/A filing on SEC EDGAR